Company’s new products are designed to address issues such as inflammation, joint pain, post-surgery pain and skin disorders in pets CBD pet market is heating up, with a growing number of cannabis companies already manufacturing products for this niche Pet … Continue reading →

Vancouver-based biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) this morning announced that it has initiated development of CBD and THC additives and formulations for the multi-billion dollar beverage industry using its patented Ready-To-Infuse-Cannabis (“RTIC”) Powder and … Continue reading →

Vancouver-based biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) this morning announced that it has accelerated development of several cannabidiol (“CBD”) products for the domestic pet food market. Pivot’s pet product line will be marketed under the … Continue reading →